P15 PROTEIN VARIANT AND USE THEREOF FOR PREVENTING OR TREATING CANCER
    11.
    发明申请
    P15 PROTEIN VARIANT AND USE THEREOF FOR PREVENTING OR TREATING CANCER 有权
    P15蛋白变异及其用于预防或治疗癌症的方法

    公开(公告)号:US20150218243A1

    公开(公告)日:2015-08-06

    申请号:US14615224

    申请日:2015-02-05

    CPC classification number: C07K14/4738 A61K38/00 C07K14/4703

    Abstract: A p15 protein variant; a polynucleotide encoding the p15 protein variant; a method for preparing the p15 protein variant; a pharmaceutical composition comprising the p15 protein variant; and a method for preventing and/or treating cancer comprising administering the p15 protein variant to a subject.

    Abstract translation: p15蛋白质变体; 编码p15蛋白变体的多核苷酸; 制备p15蛋白变体的方法; 包含该p15蛋白质变体的药物组合物; 以及用于预防和/或治疗癌症的方法,其包括将p15蛋白质变体施用于受试者。

    Polypeptide binding to annexin A1 and use thereof
    13.
    发明授权
    Polypeptide binding to annexin A1 and use thereof 有权
    多肽与膜联蛋白A1的结合及其用途

    公开(公告)号:US09522952B2

    公开(公告)日:2016-12-20

    申请号:US14482959

    申请日:2014-09-10

    Abstract: A polypeptide binding to Annexin A1, an antagonist against Annexin A1 including the polypeptide, an anti-Annexin A1 antibody including the polypeptide or an antigen-binding fragment thereof, and methods of preventing, treating and/or diagnosing a disease, including administering the antagonist and/or the antibody or an antigen-binding fragment thereof to a subject.

    Abstract translation: 与膜联蛋白A1结合的多肽,包括多肽的膜联蛋白A1的拮抗剂,包含多肽的抗间质联蛋白A1抗体或其抗原结合片段,以及预防,治疗和/或诊断疾病的方法,包括施用拮抗剂 和/或抗体或其抗原结合片段。

    P15 protein variant and use thereof for preventing or treating cancer
    14.
    发明授权
    P15 protein variant and use thereof for preventing or treating cancer 有权
    P15蛋白质变体及其用于预防或治疗癌症的用途

    公开(公告)号:US09512193B2

    公开(公告)日:2016-12-06

    申请号:US14615224

    申请日:2015-02-05

    CPC classification number: C07K14/4738 A61K38/00 C07K14/4703

    Abstract: A p15 protein variant; a polynucleotide encoding the p15 protein variant; a method for preparing the p15 protein variant; a pharmaceutical composition comprising the p15 protein variant; and a method for preventing and/or treating cancer comprising administering the p15 protein variant to a subject.

    Abstract translation: p15蛋白质变体; 编码p15蛋白变体的多核苷酸; 制备p15蛋白变体的方法; 包含该p15蛋白质变体的药物组合物; 以及用于预防和/或治疗癌症的方法,其包括将p15蛋白质变体施用于受试者。

    FUSION PEPTIDE AND USE THEREOF FOR CELL MEMBRANE PENETRATING
    19.
    发明申请
    FUSION PEPTIDE AND USE THEREOF FOR CELL MEMBRANE PENETRATING 审中-公开
    融合肽及其用于细胞膜移植的方法

    公开(公告)号:US20150119340A1

    公开(公告)日:2015-04-30

    申请号:US14527427

    申请日:2014-10-29

    CPC classification number: C12N15/87 C07K2319/10

    Abstract: A fusion peptide including a hydrophobic peptide and a basic peptide, a pharmaceutical composition including the fusion peptide, a cell membrane penetrating conjugate including the fusion peptide and a substance of interest, and a method for intracellular delivery of a substance of interest using the fusion peptide.

    Abstract translation: 包括疏水性肽和碱性肽的融合肽,包含融合肽的药物组合物,包含融合肽的细胞膜穿透缀合物和感兴趣的物质,以及使用融合肽细胞内递送感兴趣物质的方法 。

Patent Agency Ranking